RPG Life Sciences Limited — Board Meeting, 29-04-2025: Outcome of Board Meeting

RPG Life Sciences reported an audited profit of ₹11,735 Cr for the year ending March 31, 2025. The board has approved a final dividend of ₹20 per equity share, along with a special dividend of ₹4, pending shareholder approval. Leadership changes include Ms. Vasundhara Patni's appointment as a Non-Executive Director and Mr. Ashok Nair stepping in as Managing Director for three years, effective May 1, 2025. Additionally, Parikh Parekh & Associates has been appointed as Secretarial Auditors for five years.